Testing the theory of immune selection in cancers that break the rules of transplantation

Ariberto Fassati1, N Avrion Mitchison

  • 1MRC Centre for Medical Molecular Virology, University College London, UK. a.fassati@ucl.ac.uk

Insights

Cancer cells evade immune detection by down-regulating MHC molecules, a key aspect of immune surveillance. This study examines evidence for immune selection driving these changes, using transplantation experiments and natural tumor models.

Area of Science:

  • Immunology
  • Cancer Biology
  • Evolutionary Biology

Background:

  • Cancer cells often exhibit reduced immunogenicity, including down-regulation of Major Histocompatibility Complex (MHC) molecules.
  • This phenomenon is a cornerstone of the immune surveillance theory.
  • However, the direct role of immune system selection in driving these modifications is debated, with alternative explanations including metabolic changes or de-differentiation.

Purpose of the Study:

  • To evaluate the evidence supporting immune selection as the cause of cancer cell immunogenicity reduction.
  • To investigate the validity of the immune surveillance concept.

Main Methods:

  • Review of historical and contemporary transplantation experiments designed to test for immune selection.
  • Analysis of naturally occurring transmissible tumors in dogs and Tasmanian devils as models for immune surveillance.

Main Results:

  • Transplantation experiments provide insights into the selective pressures on cancer cells.
  • Naturally evolved transmissible tumors offer unique experimental systems to study immune surveillance in action.

Conclusions:

  • The study critically assesses the evidence linking cancer cell modifications to immune selection.
  • Findings from transplantation studies and natural tumor models contribute to understanding the dynamics of immune surveillance and cancer evolution.